SHE:002317 Market Cap

SHE:002317 has a market cap or net worth of 16.07 billion as of April 29, 2026. Its market cap has increased by 73.50% in one year.

Market Cap

16.07B

Enterprise Value

15.32B

Revenue

2.52B

Ranking

n/a

PE Ratio

57.30

Stock Price

18.42

Market Cap Chart

Since December 11, 2009, SHE:002317's market cap has increased from 7.22B to 16.07B, an increase of 122.75%. That is a compound annual growth rate of 5.01%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	16.07B	-0.37%
Dec 31, 2025	16.13B	56.94%
Dec 31, 2024	10.28B	-24.46%
Dec 29, 2023	13.61B	-37.64%
Dec 30, 2022	21.82B	126.34%
Dec 31, 2021	9.64B	8.90%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Shenzhen Kangtai Biological Products	15.82B
Shanghai Haoyuan Chemexpress	15.48B
Nanjing King-Friend Biochemical Pharmaceutical	15.24B
Fujian Cosunter Pharmaceutical	17.02B
China Resources Jiangzhong Pharmaceutical Co.,Ltd	15.10B
ApicHope Pharmaceutical Group	17.38B
Shandong Buchang Pharmaceuticals	17.40B
Shenzhen Hepalink Pharmaceutical Group	14.37B

Market Cap Rankings